Li Di
Li Di publishes mostly in Molecular Biology, Pharmacology and Oncology, on topics such as Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms and Computational Drug Discovery Methods.
- World rank
- #175,952 of 7,710,434 ranked researchers
- Rank in United States
- #65,766 of 1,627,098
- Works
- 319
- Citations
- 16k
- Citations per work
- 49.1
What does Li Di research?
Li Di's work is mostly in Biochemistry, Genetics and Molecular Biology (14%), Pharmacology, Toxicology and Pharmaceutics (13%), Medicine (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else15648.8%
- Life Sciences8727.4%
- Health Sciences4213.1%
- Medicine4213.1%
- Physical Sciences3410.7%
- Computer Science206.3%
- Chemistry144.4%
- 1Molecular Biology14% of their works
- 2Pharmacology13% of their works
- 3Oncology10% of their works
- 4Computational Theory and Mathematics6% of their works
- 5Spectroscopy4% of their works
- 6Neurology4% of their works
Research topics
- Pharmacogenetics and Drug Metabolism
- Drug Transport and Resistance Mechanisms
- Computational Drug Discovery Methods
- Analytical Chemistry and Chromatography
- Pharmacological Effects and Toxicity Studies
- Protein Interaction Studies and Fluorescence Analysis
- Myasthenia Gravis and Thymoma
- Metabolomics and Mass Spectrometry Studies
Which keywords describe Li Di's research?
The keywords of their largest research topics: Pharmacokinetics, Cytochrome P450, Pharmacogenetics, ATP-dependent Transporters, Multidrug Resistance, Molecular Docking, Drug Target Identification and Virtual Screening.
- Metabolomics
- Thymic Tumors
- Protein Binding
- Prenatal Exposure
- Liquid Chromatography
- Virtual Screening
- Molecular Docking
- ATP-dependent Transporters
- Cytochrome P450
- Pharmacokinetics
- Pharmacogenetics
- Multidrug Resistance
- Drug Target Identification
- Chiral Separation
- Antiepileptic Drugs
- Myasthenia Gravis
- Serum Albumin
- Mass Spectrometry
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Pharmacokinetics1552 topics
- Cytochrome P4501001 topic
- Pharmacogenetics1001 topic
- ATP-dependent Transporters731 topic
- Multidrug Resistance731 topic
- Molecular Docking702 topics
- Drug Target Identification551 topic
- Virtual Screening551 topic
- Chiral Separation311 topic
- Liquid Chromatography311 topic
- Antiepileptic Drugs191 topic
- Prenatal Exposure191 topic
- Myasthenia Gravis151 topic
- Protein Binding151 topic
- Serum Albumin151 topic
- Thymic Tumors151 topic
- Mass Spectrometry131 topic
- Metabolomics131 topic
Where does Li Di work?
Li Di's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Li Di have?
OpenAlex counts 319 works and 15,672 citations for Li Di, an h-index of 59, ranking #175,952 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Li Di
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Li Di. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.